Data as of 05:55 AM on Nov 4th, 2026
value
Data as of 06:07 AM on Nov 4th, 2026
| Vaccine | Immunizations |
|---|---|
| Td vaccine | 177.36K |
| DTaP-HepB-IPV-Hib vaccine | 117.81K |
| 15-valent pneumococcal conjugate vaccine | 112.08K |
| Measles, Mumps, and Rubella (MMR) combined vaccine | 100.68K |
| Tuberculosis vaccine | 58.86K |
| Rotavirus vaccine | 56.99K |
| DTaP-IPV vaccine | 50.84K |
| TDaP vaccine | 49.42K |
| Purified Protein Derivative (PPD) | 49.26K |
| Human papillomavirus (HPV) vaccine | 40.48K |
| Hepatitis B vaccine | 39.75K |
| DTaP-IPV-Hib vaccine | 38.35K |
| Other | 33.96K |
| Seasonal influenza vaccine | 33.61K |
| Varicella (chickenpox) vaccine | 28.35K |
| Nasal seasonal influenza vaccine | 19.72K |
| Tetanus vaccine | 17.90K |
| Rabies vaccine | 7.44K |
| 20-valent pneumococcal conjugate vaccine | 5.86K |
| 10-valent pneumococcal conjugate vaccine | 5.08K |
| COVID-19 vaccine | 3.71K |
| 13-valent pneumococcal conjugate vaccine | 1.98K |
| Combined Hepatitis A and B vaccine | 1.87K |
| Meningococcal vaccine (В) | 1.68K |
| Yellow fever vaccine | 1.40K |
| Meningococcal vaccine (A, C, W135, Y) | 1.10K |
| RSV vaccine (Respiratory Syncytial Virus vaccine) | 893 |
| Hepatitis A vaccine | 170 |
| Antitetanus serum | 139 |
| CCHF vaccine (Crimean-Congo Hemorrhagic Fever vaccine) | 89 |
Data as of 05:50 AM on Nov 4th, 2026